1	subject have enter the maintenance phase of the double-blind trial sp902 ie have take at least 1 dose of sp902 maintenance phase trial medication and either complete sp902 or meet an exit criterion in sp902 subject be allow up to 2 concomitant antiepileptic drug aeds|antiepileptic[244,257]|||||||||C0003299|932|932|antiepileptic
